IDO1 and neoplasm: Additionally, NLG919 was able to reverse the immunosuppressive TME via IDO inhibition and tumor infiltration of Treg cells, thereby inhibiting both primary and distant tumors through the photodynamic sensitized immunotherapy of iPSs.